MUNOGENICS

Munogenics is dedicated to developing therapies for the treatment of a wide variety of cancers in both humans and animals. Munogenics is a company that has completed preliminary clinical studies prooving that certain humans do have high cancer killing activity in their immune systems and these individuals can be used to donate a certain portion of their white blood cells as an entire new concept in elminating solid tumors in individuals with cancer. This technology was orginally discovered at W... ake Forest University. It is a development stage company run by two physicians and an experienced finance professional. In addition, the Company has developed an in-vitro, patent pending assay that will determine the cancer killing activity of a person’s immune system. The FDA has given the company an exemption of Phase I clinical trials and is now engaged in Phase II (a) clinical trials. It is our goal that these efforts will ultimately help millions of patients worldwide regain a normal, healthy life free of cancer. We will hold ourselves to the highest standard of integrity and work ethic in the pursuit of this goal.More